NOVO NORDISK A S (NVO) Form 6-K — Aug 4, 2026
Novo Nordisk disclosed transactions completed under its ongoing share repurchase programme. Between July 27 and August 3, 2026, the company repurchased 1,145,000 B shares for a total transaction value of DKK 371 million. Since the overall 12-month programme began on February 4, 2026, the company has repurchased a total of 27.1 million B shares for DKK 7.5 billion.
Key figures
- Repurchase Value
- DKK 7,533,256,457
- Shares Repurchased
- 27064179
- Programme Limit
- DKK 15 billion
- Recent Week Value
- DKK 370,887,565
- Treasury Shares Percent
- 1.0%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.